Eiger BioPharma reports 4Q loss
PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Monday reported a loss of $10.9 million in its fourth quarter.
On a per-share basis, the Palo Alto, California-based company said it had a loss of $1.11.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.02 per share.
For the year, the company reported that its loss narrowed to $42.4 million, or $4.86 per share.
Eiger BioPharma shares have dropped 30 percent since the beginning of the year. The stock has decreased 18 percent in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research.